What top creators are saying about BioCryst Pharmaceuticals, Inc.(BCRX)

Biotechnology company focused on rare diseases

2 AI-extracted insights from 1 source — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Based on 1 scored insight about BioCryst Pharmaceuticals, Inc..

Bullish
avg +0.30
1 bullish0 neutral0 bearish

Top creators covering BioCryst Pharmaceuticals, Inc. (BCRX)

The 1 sources with the most insights about BioCryst Pharmaceuticals, Inc. on Kazuha.

Latest insights about BioCryst Pharmaceuticals, Inc. (BCRX)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Tuesday, July 21, 2026

Bullish

Host holds a position, part of a basket of biotech plays, no detailed commentary.

Martin Shkreli
7/21/26 -2%
Martin ShkreliYouTube19 days ago

Thursday, June 25, 2026

Very Bullish
Target: $28

Significantly undervalued based on the potential of Orladeyo and phase 3 candidate Avotagabart.

Discussed alongside BioCryst Pharmaceuticals, Inc. (BCRX)

Other assets that creators frequently mention in the same content as BioCryst Pharmaceuticals, Inc..

Frequently asked

Which podcasters and creators cover BioCryst Pharmaceuticals, Inc. (BCRX) the most?

The most active sources covering BioCryst Pharmaceuticals, Inc. (BCRX) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about BioCryst Pharmaceuticals, Inc. (BCRX) are on Kazuha?

Kazuha has indexed 2 AI-extracted insights about BioCryst Pharmaceuticals, Inc. (BCRX) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside BioCryst Pharmaceuticals, Inc. (BCRX)?

Creators covering BioCryst Pharmaceuticals, Inc. (BCRX) most frequently also discuss MU, AAPL, AVGO, WDC, QCOM. See the "Discussed alongside" section above for full asset pages.